Related Experiment Videos
[Consensus soft tissue tumors. Dutch Workgroup Soft-Tissue Tumors]
A N Van Geel1, J A Van Unnik, R B Keus
1Dr. Daniel den Hoed Kliniek, afd. Chirurgische Oncologie, Rotterdam.
Nederlands Tijdschrift Voor Geneeskunde
|April 22, 1995
Summary
Soft-tissue sarcomas require multidisciplinary management for optimal prognosis, prioritizing imaging over invasive diagnostics. Early, expert intervention is crucial for managing tumor spread and improving outcomes in these rare cancers.
Area of Science:
- Oncology
- Pathology
Background:
- Soft-tissue sarcomas are rare malignant tumors originating from connective, muscular, fatty, or peripheral nervous tissues.
- Prognosis is primarily determined by tumor spread (local and remote) and biological behavior, with spread being influenced by management.
Framework:
- Multidisciplinary management is essential from diagnosis through treatment.
- Imaging diagnostics should precede invasive pathological sampling.
- Tumor mitotic rate is a key prognostic indicator.
Implementation:
- Surgical resection is the primary treatment modality.
- Radiotherapy is reserved for high-grade (grade 3) tumors, post-recurrence surgery, or to avoid mutilation.
- Chemotherapy is typically limited to clinical trials.
Implications:
- Early, expert intervention can significantly impact the management of tumor spread.
- Selected patients may benefit from surgical treatment of lung metastases.
- Regional isolated perfusion with tumor necrosis factor offers an alternative to limb amputation.